Tyra Biosciences (TYRA) Competitors $13.52 -0.30 (-2.17%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$13.52 0.00 (0.00%) As of 10/10/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TYRA vs. OGN, MOR, KNSA, HCM, TARS, BEAM, CDTX, CPRX, MLYS, and ALVOShould you be buying Tyra Biosciences stock or one of its competitors? The main competitors of Tyra Biosciences include Organon & Co. (OGN), MorphoSys (MOR), Kiniksa Pharmaceuticals International (KNSA), HUTCHMED (HCM), Tarsus Pharmaceuticals (TARS), Beam Therapeutics (BEAM), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), Mineralys Therapeutics (MLYS), and Alvotech (ALVO). These companies are all part of the "pharmaceutical products" industry. Tyra Biosciences vs. Its Competitors Organon & Co. MorphoSys Kiniksa Pharmaceuticals International HUTCHMED Tarsus Pharmaceuticals Beam Therapeutics Cidara Therapeutics Catalyst Pharmaceuticals Mineralys Therapeutics Alvotech Tyra Biosciences (NASDAQ:TYRA) and Organon & Co. (NYSE:OGN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Which has preferable earnings & valuation, TYRA or OGN? Organon & Co. has higher revenue and earnings than Tyra Biosciences. Tyra Biosciences is trading at a lower price-to-earnings ratio than Organon & Co., indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTyra BiosciencesN/AN/A-$86.48M-$1.78-7.60Organon & Co.$6.40B0.39$864M$2.693.56 Which has more volatility and risk, TYRA or OGN? Tyra Biosciences has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, Organon & Co. has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Do institutionals and insiders believe in TYRA or OGN? 84.1% of Tyra Biosciences shares are held by institutional investors. Comparatively, 77.4% of Organon & Co. shares are held by institutional investors. 15.2% of Tyra Biosciences shares are held by company insiders. Comparatively, 2.0% of Organon & Co. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to TYRA or OGN? In the previous week, Tyra Biosciences had 1 more articles in the media than Organon & Co.. MarketBeat recorded 5 mentions for Tyra Biosciences and 4 mentions for Organon & Co.. Tyra Biosciences' average media sentiment score of 0.65 beat Organon & Co.'s score of 0.53 indicating that Tyra Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tyra Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Organon & Co. 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer TYRA or OGN? Tyra Biosciences presently has a consensus price target of $31.86, indicating a potential upside of 135.63%. Organon & Co. has a consensus price target of $17.33, indicating a potential upside of 81.12%. Given Tyra Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Tyra Biosciences is more favorable than Organon & Co..Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tyra Biosciences 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.88Organon & Co. 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50 Is TYRA or OGN more profitable? Organon & Co. has a net margin of 11.15% compared to Tyra Biosciences' net margin of 0.00%. Organon & Co.'s return on equity of 163.88% beat Tyra Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Tyra BiosciencesN/A -31.22% -29.49% Organon & Co. 11.15%163.88%6.99% SummaryTyra Biosciences beats Organon & Co. on 8 of the 15 factors compared between the two stocks. Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TYRA vs. The Competition Export to ExcelMetricTyra BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$736.57M$3.38B$6.11B$10.63BDividend YieldN/A2.29%5.67%4.71%P/E Ratio-7.6022.1185.5826.57Price / SalesN/A461.00613.00132.62Price / CashN/A47.2238.5062.09Price / Book1.9910.2112.756.53Net Income-$86.48M-$52.40M$3.31B$276.43M7 Day Performance-1.02%0.86%0.81%-0.86%1 Month Performance8.42%10.39%6.22%3.58%1 Year Performance-38.38%27.24%80.35%37.94% Tyra Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TYRATyra Biosciences2.1176 of 5 stars$13.52-2.2%$31.86+135.6%-35.6%$736.57MN/A-7.6020News CoverageAnalyst ForecastOGNOrganon & Co.4.798 of 5 stars$10.84-1.5%$17.33+59.9%-46.8%$2.86B$6.40B4.034,000Analyst ForecastMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730KNSAKiniksa Pharmaceuticals International3.6326 of 5 stars$38.29-0.5%$44.29+15.7%+48.6%$2.85B$423.24M957.49220News CoverageAnalyst ForecastHCMHUTCHMED2.5025 of 5 stars$16.21+0.7%$20.88+28.8%-24.3%$2.81B$602.20M0.001,811News CoverageAnalyst ForecastTARSTarsus Pharmaceuticals0.6921 of 5 stars$67.71+3.9%$66.67-1.5%+97.6%$2.75B$182.95M-29.0650Analyst ForecastGap UpBEAMBeam Therapeutics3.0871 of 5 stars$25.89+0.5%$46.40+79.2%+14.3%$2.62B$60.27M-5.75510News CoverageAnalyst ForecastGap UpCDTXCidara Therapeutics4.0483 of 5 stars$96.45-5.4%$122.29+26.8%+974.6%$2.59BN/A-8.6790Trending NewsAnalyst ForecastGap UpCPRXCatalyst Pharmaceuticals4.7743 of 5 stars$20.73-0.5%$33.20+60.2%+2.3%$2.55B$558.50M12.5680Analyst ForecastBuyback AnnouncementMLYSMineralys Therapeutics1.7773 of 5 stars$38.01-0.1%$43.50+14.4%+214.2%$2.52BN/A-10.6828Analyst ForecastALVOAlvotech3.3118 of 5 stars$8.58+3.1%$14.00+63.2%-35.9%$2.51B$491.98M37.301,032Analyst Forecast Related Companies and Tools Related Companies OGN Alternatives MOR Alternatives KNSA Alternatives HCM Alternatives TARS Alternatives BEAM Alternatives CDTX Alternatives CPRX Alternatives MLYS Alternatives ALVO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TYRA) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
